Hurel announces partnership with Cyprotex.
Read the announcement here.
View the data sheet here.
“Make plans to attend the 12th International ISSX Meeting on July 28 – 31, 2019 in Portland, Oregon, USA.”
Q2 Solutions paper on Hurel is featured in Drug Metabolism and Disposition special issue devoted to New Models in Drug Metabolism and Transport. (download publication)
UCSF DILI study published in Toxicology Research demonstrates Hurel microlivers more predictively sensitive than 3D models. (download publication)
Nature Communications publication marks launch of HµRELviralTM infectious liver disease platform (download press release)
HµREL® featured in news article on New Jersey – based biotechs. (download article)
HµREL® Corporation Opens New, Expanded Laboratories and Corporate Headquarters in North Brunswick, New Jersey. (download press release)
HµREL® Providing Microliver Models To EPA TOXCAST Program. (download press release)
AstraZeneca: HµREL® “Superior” for studying low-CLint Compounds. (view summary)
Optivia Biotechnology Forms Technology and Marketing Alliance with HµREL® Corporation. (download press release)